JPH0566152B2 - - Google Patents

Info

Publication number
JPH0566152B2
JPH0566152B2 JP59050873A JP5087384A JPH0566152B2 JP H0566152 B2 JPH0566152 B2 JP H0566152B2 JP 59050873 A JP59050873 A JP 59050873A JP 5087384 A JP5087384 A JP 5087384A JP H0566152 B2 JPH0566152 B2 JP H0566152B2
Authority
JP
Japan
Prior art keywords
blood
denatured
fibers
stored
filter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP59050873A
Other languages
Japanese (ja)
Other versions
JPS60194959A (en
Inventor
Hitoshi Kato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Kasei Medical Co Ltd
Original Assignee
Asahi Medical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Medical Co Ltd filed Critical Asahi Medical Co Ltd
Priority to JP59050873A priority Critical patent/JPS60194959A/en
Publication of JPS60194959A publication Critical patent/JPS60194959A/en
Publication of JPH0566152B2 publication Critical patent/JPH0566152B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • External Artificial Organs (AREA)

Description

【発明の詳細な説明】 本発明は、血液または血球浮遊液中の白血球を
通過させ変性血液成分のみを捕捉するための変性
血液成分除去フイルターに関するものである。さ
らに詳しくは、繊維の直径が3〜10μm、嵩密度
が0.05〜0.45g/cm2で、繊維の互いのもつれによ
り固定された不織布からなり、その厚さが0.05〜
0.35mmであり、かつ、その総表面積が15〜2000
cm2/500ml−保存血である、白血球を通過させ変
性血液成分のみを捕捉するための変性血液成分除
去フイルターに関するものである。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a denatured blood component removal filter for passing leukocytes in blood or a blood cell suspension and capturing only denatured blood components. More specifically, the fibers have a diameter of 3 to 10 μm, a bulk density of 0.05 to 0.45 g/ cm2 , are made of a nonwoven fabric fixed by mutual entanglement of fibers, and have a thickness of 0.05 to 0.45 g/cm2.
0.35mm and its total surface area is 15~2000
cm 2 /500ml - This relates to a denatured blood component removal filter for passing leukocytes and capturing only denatured blood components, which is stored blood.

最近、輸血に先立ち、血液中の変性血液成分を
除去する操作を行うようになつてきた。この変性
血液成分は、血液を保存したときに多く発生し、
特に長期保存するにしたがつて、その数が増加
し、かつ、大きく成長する。
Recently, procedures have been performed to remove denatured blood components from blood prior to blood transfusion. This denatured blood component often occurs when blood is stored,
In particular, as they are stored for a long period of time, their number increases and grows significantly.

これらの変性血液成分のうち大きなものを除去
するフイルターとしては、例えば、特開昭51−
111960号の20μmの織布フイルターがあるが、大
きな変性血液成分のみを除去するフイルターであ
り、血液中の小さな変性血液成分である凝集物質
(Microaggregate)、すなわち、大きさにして15
〜20μmのものは完全に除去できなかつた。これ
ら小さな凝集物質でも、大量輸血時に肺毛細管の
閉塞などを起し易いという問題がある。これら小
さな凝集物質が完全に除去できる変性血液成分除
去フイルターとしては、例えば、特開昭51−4891
号の厚さ0.381mm以上に繊維を詰め込んだ変性血
液成分除去フイルターがあるが、微小集合体が完
全に除去できても、その処理速度が20ml/分前後
とその処理速度が遅く、血液500ml位を処理する
となると、血液センター、病院などで使用する場
合、少々長すぎる処理時間であり、また、この
間、血液または血球浮遊液を室温放置すれば、血
液の変性が進むという問題があつた。
For example, as a filter for removing large denatured blood components,
There is a 20 μm woven fabric filter No. 111960, but it is a filter that only removes large denatured blood components, and it removes microaggregates, which are small denatured blood components in blood, that is, 15 μm in size.
Those with a diameter of ~20 μm could not be completely removed. There is a problem in that even these small aggregates tend to cause pulmonary capillary occlusion during large-scale blood transfusion. For example, denatured blood component removal filters that can completely remove these small aggregates include JP-A No. 51-4891.
There is a denatured blood component removal filter packed with fibers with a thickness of 0.381 mm or more, but even if micro aggregates can be completely removed, the processing speed is slow at around 20 ml/min, and the processing speed is slow at around 500 ml of blood. When used in blood centers, hospitals, etc., the processing time is a little too long, and if the blood or blood cell suspension is left at room temperature during this time, there is a problem that denaturation of the blood progresses.

本発明者は、血液中の大きな変性血液成分から
15〜20μm位の凝集物質まで完全に除去できて、
しかも、高速処理のできる変性血液成分除去フイ
ルターの開発を目標に鋭意検討した結果、直径が
3〜10μmの繊維からなり、嵩密度が0.05〜
0.45g/cm2で、繊維の互いにもつれにより固定さ
れた不織布からなり、その厚さが0.05〜0.35mmで
あり、かつ、その総表面積が15〜2000cm2/500ml
−保存血である変性血液成分除去フイルターが、
血液中の大きな変性血液成分から15〜20μm位の
凝集物質までの全ての変性血液成分を除去でき、
長期保存血中に存在する変性蛋白のような粘着物
質も捕捉することができて、しかも、70〜100
ml/分位の高速処理ができることを見出した。
The inventor has discovered that large degenerated blood components in the blood
It can completely remove aggregated substances up to 15-20μm,
Moreover, as a result of intensive research aimed at developing a filter for removing denatured blood components that can be processed at high speed, we found that it consists of fibers with a diameter of 3 to 10 μm and a bulk density of 0.05 to 10 μm.
0.45g/ cm2 , made of non-woven fabric fixed by intertwining of fibers, its thickness is 0.05-0.35mm, and its total surface area is 15-2000cm2 /500ml
-A filter for removing denatured blood components, which is stored blood,
It can remove all denatured blood components from large denatured blood components to aggregates of 15 to 20 μm.
It can also capture sticky substances such as denatured proteins that exist in long-term stored blood, and it
It has been found that high-speed processing on the order of ml/minute is possible.

血液は、赤血球、白血球、血小板および血漿な
どを含有するが、赤血球の直径は8〜10μmであ
り、白血球の直径は12〜20μmである。変性血液
成分の凝集物質は、小さいものは15〜20μmで、
白血球との大きさの差がなくなつてくるが、変性
血液成分除去フイルターに使用する繊維の太さを
極端に細くし、繊維間の間隙を小さくすれば、白
血球、赤血球がくぐり抜けることができ、かつ、
血液中の凝集物質は捕捉されること、この際、使
用する繊維は、変性血液成分を吸着する性質のあ
る繊維であり、かつ、長期保存血中に存在する変
性蛋白のような粘着物質を捕捉する性質のある繊
維が好ましいことが判つた。
Blood contains red blood cells, white blood cells, platelets, plasma, etc., and the diameter of red blood cells is 8 to 10 μm, and the diameter of white blood cells is 12 to 20 μm. Agglutinated substances of denatured blood components are as small as 15 to 20 μm.
The difference in size from white blood cells disappears, but if the thickness of the fibers used in the denatured blood component removal filter is made extremely thin and the gaps between the fibers are made small, white blood cells and red blood cells can pass through. and,
Agglutinated substances in blood are captured; in this case, the fibers used are fibers that have the property of adsorbing denatured blood components, and also capture sticky substances such as denatured proteins that exist in long-term stored blood. It has been found that fibers that have the property of

本発明において好ましい繊維、すなわち、変性
血液成分を吸着する性質があり、変性蛋白のよう
な粘着物質を捕捉する性質のある繊維としては、
合成繊維として、ポリエステル、ポリアミド、芳
香族ポリアミド、、ポリアクリロニトリル系繊維
などがあり、再生繊維として、キプラアンモニウ
ムレーヨンなどがある。
Preferred fibers in the present invention, that is, fibers that have the property of adsorbing denatured blood components and capturing sticky substances such as denatured proteins, include:
Examples of synthetic fibers include polyester, polyamide, aromatic polyamide, and polyacrylonitrile fibers, and examples of recycled fibers include cypra ammonium rayon.

本発明において、繊維の直径は3〜10μmの範
囲であり、好ましくは4〜8μmの範囲である。繊
維の直径が3〜10μmの太さの繊維を作ること、
およびこれを均一な不織布にすることは、一般に
は難しいことである。10μm以下の繊維を作る方
法としては、例えば、溶融ブロー法(Melt−
blowing process)があり、この方法により、本
発明の繊維および不織布を作成した。しかし、本
発明に使用する繊維は、この方法に限定されるも
のではない。繊維の直径が3μmより小さくなる
と、白血球も捕捉されるようになり、また、
10μmより大きくなると、繊維間の間隙が大きく
なり、高速処理では凝集物質が完全に除去できな
くなつてくる。
In the present invention, the diameter of the fibers ranges from 3 to 10 μm, preferably from 4 to 8 μm. Creating fibers with a diameter of 3 to 10 μm,
It is generally difficult to make this into a uniform nonwoven fabric. Examples of methods for producing fibers of 10 μm or less include the melt-blowing method (Melt-blowing method).
The fibers and nonwoven fabrics of the present invention were produced by this method. However, the fibers used in the present invention are not limited to this method. When the fiber diameter becomes smaller than 3 μm, leukocytes are also captured, and
When the diameter exceeds 10 μm, the gaps between the fibers become large, and the aggregated substances cannot be completely removed by high-speed processing.

本発明の不織布は、繊維が繊維の互いのもつれ
によりその位置に固定されている繊維状物であ
り、この繊維と繊維間の固定法としては、これら
の繊維の融点付近の熱を加えて熱固着させたり、
接着剤による固定法があり、これらは勿論、本発
明に使用できるが、本発明で使用する繊維のよう
に繊維が細くなると、溶融ブロー法により繊維を
作るため、その時のエアーブロー法、、高圧蒸気
ブロー法などにより、繊維を互いにもつれさせる
だけで繊維間がその位置に固定され、熱固着など
を行わなくても、このように作成した不織布は、
例えば、破壊するような大きな力を加えない限り
安定であり、血液処理にも充分耐えることができ
る。したがつて、このように完全に固着させない
エアーブロー法、高圧蒸気ブロー法などによる単
に繊維を互いにもつれさせるだけの繊維の固定法
も、本発明の不織布の固定法として使用できる。
The nonwoven fabric of the present invention is a fibrous material in which the fibers are fixed in position by mutual entanglement of the fibers, and the method of fixing the fibers is by applying heat near the melting point of these fibers. Fix it or
There are fixing methods using adhesives, and these can of course be used in the present invention, but when the fibers become thin like the fibers used in the present invention, the fibers are made by melt blowing, so air blowing, high pressure, etc. By simply entangling the fibers with each other using a method such as steam blowing, the fibers are fixed in place, and the nonwoven fabric created in this way can be
For example, it is stable unless large forces are applied that would destroy it, and it can withstand blood treatment. Therefore, methods of fixing fibers such as air blowing, high pressure steam blowing, etc., which do not completely fix the fibers, but simply entangle the fibers with each other, can also be used as the method of fixing the nonwoven fabric of the present invention.

本発明の変性血液成分除去フイルターの嵩密度
は0.05〜0.45g/cm2の範囲であり、好ましくは0.10
〜0.40g/cm2の範囲である。嵩密度が0.05g/cm2
り小さくなると、繊維間の間隙が大きくなり、凝
集物質が完全に除去できなくなつてくる。また、
嵩密度が0.45g/cm2より大きくなると、繊維間の
間隙が緻密になり、白血球も捕捉されるようにな
る。
The bulk density of the denatured blood component removal filter of the present invention is in the range of 0.05 to 0.45 g/ cm2 , preferably 0.10 g/cm2.
~0.40g/ cm2 . When the bulk density is less than 0.05 g/cm 2 , the gaps between the fibers become large and the aggregated substances cannot be completely removed. Also,
When the bulk density is greater than 0.45 g/cm 2 , the gaps between the fibers become dense and white blood cells are also captured.

本発明の変性血液成分除去フイルターの厚さは
0.05〜0.35mmの範囲であり、好ましくは0.10〜
0.30mmの範囲である。変性血液成分除去フイルタ
ーの厚さが0.05mmより薄いと、凝集物質を完全に
捕捉することが難しくなる。また、0.35mmより厚
くなると、処理速度が遅くなり、かつ、白血球の
回収率が落ちてくる。
The thickness of the denatured blood component removal filter of the present invention is
In the range of 0.05~0.35mm, preferably 0.10~
The range is 0.30mm. When the thickness of the denatured blood component removal filter is thinner than 0.05 mm, it becomes difficult to completely capture aggregated substances. Moreover, if it becomes thicker than 0.35 mm, the processing speed becomes slow and the recovery rate of white blood cells decreases.

血液または血球浮遊液中の変性血液成分は、血
液を保存したときに多く発生し、保存期間の長さ
により、凝集物質の量および大きさが異なるの
で、その保存期間の長さにより、変性血液成分除
去フイルターの必要面積は異なるが、繊維間の間
隙部を含めた血液入口側の総表面積(以下、フイ
ルター面積という)が15cm2/保存血500mlから
2000cm2/保存血500mlの範囲にあること、好まし
くは20cm2/保存血500mlから1000cm2/保存血500ml
の範囲であること、さらに好ましくは30cm2/保存
血500mlから500cm2/保存血500mlの範囲である。
フイルター面積が15cm2/保存血500mlより小さく
なると、変性血液成分除去フイルターの表面が変
性血液成分で飽和されてくるため、処理速度が遅
くなつてくる。また、フイルター面積が2000cm2
保存血500mlより大きくなると、変性血液成分除
去処理後のフイルター内の血球回収のための生理
食塩水が多量に必要であり、さらに、変性血液成
分除去フイルター内に残る血球も多くなるため、
白血球、赤血球の回収率が低下してくる。
Many denatured blood components in blood or blood cell suspension occur when blood is stored, and the amount and size of aggregated substances vary depending on the length of the storage period. The area required for the component removal filter varies, but the total surface area on the blood inlet side including the gaps between fibers (hereinafter referred to as filter area) is from 15 cm 2 / 500 ml of stored blood.
Must be in the range of 2000cm 2 /500ml of stored blood, preferably 20cm 2 /500ml of stored blood to 1000cm 2 /500ml of stored blood
More preferably, the area is between 30 cm 2 /500 ml of stored blood and 500 cm 2 /500 ml of stored blood.
When the filter area is smaller than 15 cm 2 /500 ml of stored blood, the surface of the denatured blood component removal filter becomes saturated with denatured blood components, and the processing speed becomes slow. Also, the filter area is 2000cm 2 /
If the stored blood exceeds 500ml, a large amount of physiological saline will be required to collect blood cells in the filter after denatured blood component removal processing, and more blood cells will remain in the denatured blood component removal filter.
The recovery rate of white blood cells and red blood cells decreases.

血液または血球浮遊液をフイルターに通過させ
る速度は、本発明によれば高速で行うことができ
るのであるが、採取した血液の保存期間や、血液
入口側のフイルター面積により異なり、一般に25
〜140ml/分の範囲であり、好ましくは30〜110
ml/分、さらに好ましくは約70〜100ml/分の範
囲である。
According to the present invention, the speed at which the blood or blood cell suspension is passed through the filter can be high, but it varies depending on the storage period of the collected blood and the area of the filter on the blood inlet side, and is generally 25
~140ml/min, preferably 30-110
ml/min, more preferably in the range of about 70-100 ml/min.

本発明の目的、すなわち、多量の血液または血
球浮遊液から簡単な操作で、大きな変性血液成分
の凝集物質から小さな凝集物質まで全てを、高速
処理により短時間に除去する目的を達成するため
には、直径が3〜10μmの細い繊維を使用し、嵩
密度が0.05〜0.45g/cm2で繊維の互いのもつれに
より固定された不織布にして、繊維間の間隙を極
度に小さくし、赤血球、白血球をくぐり抜けさ
せ、変性血液成分を捕捉し、不織布の厚さを0.05
〜0.35mmにすることにより、処理液の圧損を小さ
くして高流速にすることである。
In order to achieve the purpose of the present invention, that is, to remove everything from large aggregates of denatured blood components to small aggregates from a large amount of blood or blood cell suspension in a short time by high-speed processing with simple operations. , using thin fibers with a diameter of 3 to 10 μm and a bulk density of 0.05 to 0.45 g/cm 2 and fixed by entangling the fibers with each other, making the gap between the fibers extremely small, making it possible to reduce red blood cells and white blood cells. The thickness of the non-woven fabric is reduced to 0.05 to capture denatured blood components.
By setting the diameter to ~0.35 mm, the pressure drop of the processing liquid can be reduced and the flow rate can be increased.

以下、図面によつて本発明の変性血液成分除去
フイルターおよび該フイルターによるフイルター
装置の詳細を説明する。
DESCRIPTION OF THE PREFERRED EMBODIMENTS The details of the denatured blood component removal filter of the present invention and a filter device using the filter will be explained below with reference to the drawings.

第1図および第2図は、本発明の変性血液成分
除去フイルターによるフイルター装置の一実施態
様を示し、第3図および第4図は、別の実施態様
を示すものである。第1図および第2図におい
て、1はフイルター装置本体で、二つの丸盆状枠
体2,2′が空胴部を形成するように、リング部
材3で嵌合し、丸盆状枠体2,2′の内面には、
それぞれ多数の突条4,4′が形成され、その内
側に、メツシユ状支持材5,5′に挾まれて、不
織布からなるフイルター6が設けられている。7
は一方の丸盆状枠体2に設けられた血液流入管、
8は他方の丸盆状枠体2′に設けられた血液流出
管であり、9,9′はパツキングである。そして、
フイルター6はメツシユ状支持材5,5′によつ
て保持されている。
1 and 2 show one embodiment of a filter device using the denatured blood component removal filter of the present invention, and FIGS. 3 and 4 show another embodiment. In FIGS. 1 and 2, 1 is a filter device main body, and two round tray-shaped frames 2 and 2' are fitted with a ring member 3 so as to form a cavity. On the inside of 2,2′,
A large number of protrusions 4, 4' are formed respectively, and a filter 6 made of non-woven fabric is provided inside the protrusions 4, 4' sandwiched between mesh-like supporting members 5, 5'. 7
is a blood inflow pipe provided in one round tray-shaped frame 2,
8 is a blood outflow pipe provided in the other round tray-shaped frame 2', and 9 and 9' are packings. and,
The filter 6 is held by mesh-like supports 5, 5'.

第3図および第4図のフイルター装置も、前記
フイルター装置とほぼ同様であるが、血液流入管
13および血液流出管14が丸盆状枠体10,1
0′のそれぞれ中心部に設けられ、空胴部には、
メツシユ状支持材11,11′に挾まれて、不織
布からなるフイルター12が設けられている。1
5,15′はパツキングである。
The filter devices shown in FIGS. 3 and 4 are also substantially similar to the filter device described above, except that the blood inflow pipe 13 and the blood outflow pipe 14 are connected to the round tray-shaped frames 10 and 1.
0' in the center, and in the cavity,
A filter 12 made of non-woven fabric is provided sandwiched between mesh-like supports 11, 11'. 1
5, 15' is packing.

血液または血球浮遊液は、血液流入管7あるい
は13から導入され、メツシユ状支持材5あるい
は11において、変性血液成分除去フイルター6
あるいは12の表面全体に広がり、変性血液成分
除去フイルターに均一に流れ込み、変性血液成分
が捕捉除去されて、メツシユ状支持材5′あるい
は11′を通り、血液流出管8あるいは14より
回収されることになる。
Blood or blood cell suspension is introduced from the blood inflow pipe 7 or 13, and passed through the denatured blood component removal filter 6 in the mesh-like support material 5 or 11.
Alternatively, it spreads over the entire surface of 12, flows uniformly into the denatured blood component removal filter, captures and removes denatured blood components, passes through the mesh-like support material 5' or 11', and is collected from the blood outflow tube 8 or 14. become.

第5図は、前記本発明の変性血液成分除去フイ
ルターによるフイルター装置の一使用態様を示す
ものである。
FIG. 5 shows one mode of use of the filter device using the denatured blood component removal filter of the present invention.

血液または血球浮遊液は、採血バツグ16から
落差圧により、回路17を通り、本発明の変性血
液成分除去フイルターによるフイルター装置18
に供給される。変性血液成分除去フイルター部で
変性血液成分が捕捉され、変性血液成分を除去さ
れた血液または血球浮遊液が回路19を通り、回
収バツグ20に回収される。赤血球、白血球など
の回収率を高めるため、あらかじめ用意した生理
食塩水バツグ21より、同様にして、回路22、
変性血液成分除去フイルター装置18、回路1
9、回収バツグ20に生理食塩水を流し、回路お
よび変性血液成分除去フイルター部に残存してい
る血液または血球浮遊液を生理食塩水で置換して
回収する。23は回収バツグ、24は調整バルブ
である。なお、本発明の不織布の嵩密度とは、均
一な不織布1cm2当りの、その重さを測定した値を
言う。
The blood or blood cell suspension is passed through a circuit 17 from the blood collection bag 16 by the differential pressure, and is passed through a filter device 18 using the denatured blood component removal filter of the present invention.
supplied to The denatured blood components are captured by the denatured blood component removal filter section, and the blood or blood cell suspension from which the denatured blood components have been removed passes through a circuit 19 and is collected into a collection bag 20. In order to increase the recovery rate of red blood cells, white blood cells, etc., from a physiological saline bag 21 prepared in advance, the circuit 22,
Denatured blood component removal filter device 18, circuit 1
9. Physiological saline is poured into the collection bag 20, and the blood or blood cell suspension remaining in the circuit and the denatured blood component removal filter is replaced with physiological saline and collected. 23 is a collection bag, and 24 is a regulating valve. Incidentally, the bulk density of the nonwoven fabric of the present invention refers to the value measured by the weight per 1 cm 2 of a uniform nonwoven fabric.

以上述べたように、本発明による変性血液成分
除去フイルターは、血液または血球浮遊液中の変
性血液成分中の大きな凝集物質から15〜20μmの
凝集物質まで、早い処理時間で完全に除去するこ
とが容易に行えるものである。
As described above, the filter for removing denatured blood components according to the present invention can completely remove large aggregates to 15-20 μm aggregates from denatured blood components in blood or blood cell suspensions in a short processing time. It's easy to do.

以下、実施例を挙げて説明する。 Examples will be described below.

実施例 1 直径6.4μmのポリエステル繊維を溶融ブロー法
で作成した嵩密度0.35g/cm2の繊維塊が繊維の互
いのもつれによつてその位置に固定されている不
織布を、直径110mm、厚さ0.20mmの円柱状に切断
し、有効内径100mm(有効内径=血液または血球
浮遊液が実際にフイルター表面に接触する部分の
径を示す、以下の実施例も同じ)、内部空間部の
厚さが5mmのカラム中に固定した。得られた変性
血液成分除去フイルターの血液入口側の総表面積
は98cm2/500ml−保存血であつた。300mlの採血バ
ツグ2個からそれぞれ落差800mmの位置に、上記
の変性血液成分除去フイルター装置をつけ、さら
に800mm下方に1の輸液バツグをつけて、処理
した液を貯蔵する回収バツグとし、その間をそれ
ぞれ内径3mm、外径5mmのチユーブで連結した処
理装置を作成した。
Example 1 A nonwoven fabric with a diameter of 110 mm and a thickness of polyester fibers of 6.4 μm in diameter and a bulk density of 0.35 g/cm 2 made by a melt-blowing method was fixed in place by the mutual entanglement of the fibers. Cut into a 0.20 mm cylinder, with an effective inner diameter of 100 mm (effective inner diameter = diameter of the part where blood or blood cell suspension actually contacts the filter surface; the same applies to the following examples), and a thickness of the inner space. It was fixed in a 5 mm column. The total surface area on the blood inlet side of the resulting denatured blood component removal filter was 98 cm 2 /500 ml of stored blood. Attach the above-mentioned denatured blood component removal filter device at a height of 800 mm from the two 300 ml blood collection bags, and then attach one infusion bag 800 mm below, which serves as a collection bag to store the processed fluid, and between each A processing device was created that was connected by tubes with an inner diameter of 3 mm and an outer diameter of 5 mm.

この処理装置の採血バツグ2個に、A型の健康
人のヘマトクリツト36%の14日間保存したCPD
液添加血液全血200mlずつを入れ、落差を利用し
た自然落下法により、室温25℃で1バツグずつ順
番に変性血液成分除去処理を行つた。
In two blood collection bags of this processing device, CPD with a hematocrit of 36% from a healthy type A patient was stored for 14 days.
200 ml of whole blood was added to each bag, and denatured blood components were removed one by one at a room temperature of 25° C. using a gravity drop method using a drop.

つぎに、生理食塩水40mlを自然落下法により、
この変性血液成分除去フイルター装置に流し、フ
イルター装置内の血球を回収した。
Next, add 40ml of physiological saline using the gravity drop method.
The blood was passed through this filter device for removing denatured blood components, and the blood cells in the filter device were collected.

その結果、この保存血液400mlの処理時間は4
分13秒であり、処理速度にして95ml/分という高
速流であつた。また、この14日間保存血の変性血
液成分の凝集物質が、処理前15μm以上で、2バ
ツグの平均が1.65×106個/ml存在したのが、処
理後は0個/mlであつた。さらに、白血球回収率
は91.4%、赤血球回収率は92.3%であつた。
As a result, the processing time for 400ml of this stored blood was 4
The processing time was 95 ml/min, which was a high-speed flow. In addition, the aggregated substances of denatured blood components in the blood stored for 14 days were 15 μm or more before treatment, and the average of 2 bags was 1.65×10 6 particles/ml, but after treatment, it was 0 particles/ml. Furthermore, the leukocyte recovery rate was 91.4% and the red blood cell recovery rate was 92.3%.

比較例 1 直径が13μm、長さが40〜70mmのポリエステル
繊維を、内径が100mm、厚さ35mmの円柱状カラム
の血液流入部に厚さ5mmの空間ができるようにし
て、内径100mm、厚さ30mm部に16gを均一に詰め
た変性血液成分除去フイルター装置(嵩密度
0.20g/cm2)を作成した。得られた変性血液成分
除去フイルターの血液入口側の総表面積は98cm2
500ml−保存血であつた。300mlの採血バツグ2個
からそれぞれ落差800mmの位置に、上記の変性血
液成分除去フイルター装置をつけ、さらに800mm
下方に1の輸液バツグをつけて、処理した血液
を貯蔵する回収バツグとし、その間をそれぞれ内
径3mm、外径5mmのチユーブで連結した処理装置
を作成した。
Comparative Example 1 Polyester fibers with a diameter of 13 μm and a length of 40 to 70 mm were placed in a cylindrical column with an inner diameter of 100 mm and a thickness of 35 mm, with a space of 5 mm thick at the blood inflow part. Denatured blood component removal filter device (bulk density
0.20g/cm 2 ). The total surface area on the blood inlet side of the obtained denatured blood component removal filter was 98 cm 2 /
500ml - stored blood. Attach the above-mentioned denatured blood component removal filter device at a height of 800 mm from two 300 ml blood collection bags, and add another 800 mm.
A processing device was constructed in which an infusion bag was attached to the bottom to serve as a collection bag for storing treated blood, and the bag was connected with a tube having an inner diameter of 3 mm and an outer diameter of 5 mm.

この処理装置の採血バツグ2個に、A型の健康
人のヘマトクリツト36%の14日間保存したCPD
液添加血液全血200mlずつを入れ、落差を利用し
た自然落下法により、室温25℃で1バツグずつ順
番に変性血液成分除去処理を行つた。
In two blood collection bags of this processing device, CPD with a hematocrit of 36% from a healthy type A patient was stored for 14 days.
200 ml of whole blood was added to each bag, and denatured blood components were removed one by one at a room temperature of 25° C. using a gravity drop method using a drop.

つぎに、生理食塩水257mlを自然落下法により、
この変性血液成分除去フイルター装置に流し、フ
イルター装置内の血球を回収した。
Next, add 257 ml of physiological saline using the gravity method.
The blood was passed through this filter device for removing denatured blood components, and the blood cells in the filter device were collected.

その結果、この保存血液400mlの処理時間は21
分3秒であり、処理速度にして19ml/分であつ
た。また、この14日間保存血の変性血液成分の凝
集物質が、処理前15μm以上で、2バツグの平均
が1.48×106個/ml存在したのが、処理後は0.51×
106個/ml(凝集物質の除去率65.5%)であつた。
さらに、白血球の回収率は84.8%、赤血球回収率
は89.7%であつた。
As a result, the processing time for 400ml of this stored blood is 21
The processing time was 19 ml/min. In addition, the aggregated substances of denatured blood components in the blood stored for 14 days were 15 μm or more before treatment, and the average of 2 bags was 1.48 × 10 6 /ml, but after treatment, it was 0.51
106 particles/ml (removal rate of aggregated substances 65.5%).
Furthermore, the recovery rate of white blood cells was 84.8% and the recovery rate of red blood cells was 89.7%.

実施例1によれば、本発明の変性血液成分除去
フイルターは、従来の変性血液成分除去フイルタ
ーと比較して約5倍の高速処理であり、変性血液
成分の除去性能も、従来法と比較して非常に良好
であつた。
According to Example 1, the denatured blood component removal filter of the present invention has a processing speed that is about 5 times faster than that of the conventional denatured blood component removal filter, and the denatured blood component removal performance is also higher than that of the conventional method. It was very good.

実施例 2 直径4.6μmのポリエステル繊維を溶融ブロー法
で作成した嵩密度0.18g/cm2の不織布を製造する
際に、溶融ブロー時250℃で2秒間乾熱処理し、
繊維の互いにもつれ合つた接点を熱固着した不織
布を作成した。この不織布を直径78mm、厚さ0.25
mmの円柱状に切断し、有効内径68mm、内部空間部
の厚さが5mmのカラム中に固定した。得られた変
性血液成分除去フイルターの血液入口側の総表面
積は45cm2/500ml−保存血であつた。300mlの採血
バツグ2個からそれぞれ落差800mmの位置に、上
記の変性血液成分除去フイルター装置をつけ、さ
らに800mm以下に1の輸液バツグをつけて、処
理した液を貯蔵する回収バツグとし、その間をそ
れぞれ内径3mm、外径5mmのチユーブで連結した
処理装置を作成した。
Example 2 When manufacturing a nonwoven fabric with a bulk density of 0.18 g/cm 2 made by melt-blowing polyester fibers with a diameter of 4.6 μm, dry heat treatment was performed at 250°C for 2 seconds during melt-blowing.
A nonwoven fabric was created by thermally fixing the intertwined contact points of fibers. This nonwoven fabric has a diameter of 78 mm and a thickness of 0.25 mm.
It was cut into cylindrical pieces with a diameter of 68 mm and fixed in a column with an effective inner diameter of 68 mm and an internal space thickness of 5 mm. The total surface area on the blood inlet side of the resulting denatured blood component removal filter was 45 cm 2 /500 ml of stored blood. Attach the above-mentioned denatured blood component removal filter device at a height of 800 mm from two 300 ml blood collection bags, and then attach one infusion bag below 800 mm to serve as a collection bag for storing the processed fluid, and between each A processing device was created that was connected by tubes with an inner diameter of 3 mm and an outer diameter of 5 mm.

この処理装置の採血バツグ2個に、B型の健康
人のヘマトクリツト45%の8日間保存したACD
−A液添加血液全血200mlずつ入れ、落差を利用
した自然落下法により、室温25℃で1バツグずつ
順番に変性血液成分処理を行つた。
ACD with a hematocrit of 45% from a healthy blood type B patient stored for 8 days was stored in two blood collection bags of this processing device.
- Blood added with liquid A 200 ml of whole blood was added to each bag, and denatured blood components were treated one by one at a room temperature of 25° C. using a gravity drop method using a drop.

つぎに、生理食塩水30mlを自然落下法により、
この変性血液成分除去フイルター装置に流し、フ
イルター装置内の血球を回収した。
Next, add 30ml of physiological saline using the gravity drop method.
The blood was passed through this filter device for removing denatured blood components, and the blood cells in the filter device were collected.

その結果、この保存血液400mlの処理時間は3
分58秒であり、処理速度にして101ml/分という
高流速であつた。また、この8日間保存血の変性
血液成分の凝集物質が、処理前15μm以上で、2
バツグの平均が0.91×106個/ml存在したのが、
処理後は18700個/ml(凝集物質の除去率97.9
%)、さらに、白血球回収率93.2%、赤血球回収
率は96.1%であつた。
As a result, the processing time for 400ml of this stored blood was 3
The processing time was 101 ml/min, which was a high flow rate. In addition, if the agglutinated substances of the denatured blood components of the blood stored for these 8 days were 15 μm or more before treatment, 2
There was an average of 0.91×10 6 cells/ml,
After treatment: 18,700 particles/ml (removal rate of aggregated substances: 97.9)
%), and the leukocyte recovery rate was 93.2% and the red blood cell recovery rate was 96.1%.

比較例 2 直径が18μm、長さが40〜70mmのポリアミド繊
維(ナイロン66)を、内径が68mm、厚さ30mmの円
柱状カラムの血液流入部に厚さ5mmの空間ができ
るようにして、内径68mm、厚さ25mm部に27gを均
一に詰めた変性血液成分除去フイルター装置(嵩
密度0.30g/cm2)を作成した。得られた変性血液
成分除去フイルターの血液入口側の総表面積は45
cm2/500ml−保存血であつた。300mlの採血バツグ
2個からそれぞれ落差800mmの位置に、上記の変
性血液成分除去フイルター装置をつけ、さらに
800mm下方に1の輸液バツグをつけて、処理し
た血液を貯蔵する回収バツグとし、その間をそれ
ぞれ内径3mm、外径5mmのチユーブで連結した処
理装置を作成した。
Comparative Example 2 Polyamide fibers (nylon 66) with a diameter of 18 μm and a length of 40 to 70 mm were made into a cylindrical column with an inner diameter of 68 mm and a thickness of 30 mm, with a space of 5 mm thick at the blood inflow part. A denatured blood component removal filter device (bulk density: 0.30 g/cm 2 ) was prepared by uniformly packing 27 g into a 68 mm and 25 mm thick section. The total surface area of the obtained denatured blood component removal filter on the blood inlet side is 45
cm 2 /500ml - stored blood. Attach the above denatured blood component removal filter device at a height of 800 mm from two 300 ml blood collection bags, and
A processing device was constructed in which an infusion bag was attached 800 mm below the bag to serve as a collection bag for storing treated blood, and the bag was connected with a tube having an inner diameter of 3 mm and an outer diameter of 5 mm.

この処理装置の採血バツグ2個に、B型の健康
人のヘマトクリツト45%の8日間保存したACD
−A液添加血液全血200mlずつを入れ、落差を利
用した自然落下法により、室温25℃でバツグずつ
順番に変性血液成分除去処理を行つた。
ACD with a hematocrit of 45% from a healthy blood type B patient stored for 8 days was stored in two blood collection bags of this processing device.
-Blood containing A solution 200 ml of whole blood was added to each bag, and denatured blood components were removed one by one bag by bag at a room temperature of 25° C. using a gravity drop method using a drop.

つぎに、生理食塩水120mlを自然落下法により、
この変性血液成分除去フイルター装置に流し、フ
イルター装置内の血球を回収した。
Next, add 120ml of physiological saline using the gravity drop method.
The blood was passed through this filter device for removing denatured blood components, and the blood cells in the filter device were collected.

その結果、この保存血液400mlの処理時間は22
分13秒であり、処理速度にして18ml/分であつ
た。また、、8日間保存血の変性血液成分の凝集
物質が、処理前15μm以上で、2バツグの平均が
0.82×106個/ml存在したのが、処理後は0.23×
106個/ml(凝集物質の除去率72.0%)であつた。
さらに、白血球の回収率は81.2%、赤血球の回収
率は85.9%であつた。
As a result, the processing time for 400ml of this stored blood is 22
The processing time was 13 minutes and 13 seconds, and the processing speed was 18 ml/minute. In addition, the aggregated substances of denatured blood components in blood stored for 8 days were 15 μm or more before treatment, and the average of 2 bags was
There were 0.82×10 6 cells/ml, but after treatment it was 0.23×
106 particles/ml (removal rate of aggregated substances 72.0%).
Furthermore, the recovery rate of white blood cells was 81.2% and the recovery rate of red blood cells was 85.9%.

実施例2によれば、本発明の変性血液成分除去
フイルターは、従来の変性血液成分除去フイルタ
ーと比較して約6倍の高速処理であり、変性血液
成分の除去性能も、従来法と比較して非常に良好
であつた。
According to Example 2, the denatured blood component removal filter of the present invention has a processing speed approximately 6 times faster than the conventional denatured blood component removal filter, and the denatured blood component removal performance is also higher than that of the conventional method. It was very good.

実施例 3 直径が5.2μmのポリアミド繊維(ナイロン66)
を溶融ブロー法により作成した嵩密度0.26g/cm2
の繊維塊が繊維の互いのもつれによつてその位置
に固定されている不織布を、直径170mm、厚さ
0.20mmの円柱状に切断し、有効内径160mm、内部
空間部の厚さが5mmのカラムの中に固定した。得
られた変性血液成分除去フイルターの血液入口側
の総表面積は201cm2/500ml−保存血であつた。
300mlの採血バツグ2個からそれぞれ落差800mmの
位置に、上記の変性血液成分除去フイルターをつ
け、さらに800mm下方に1の輸液バツグをつけ
て、処理した液を貯蔵する回収バツグとし、その
間をそれぞれ内径3mm、外径5mmのチユーブで連
結した処理装置を作成した。
Example 3 Polyamide fiber (nylon 66) with a diameter of 5.2 μm
Bulk density 0.26g/cm 2 made by melt blowing method
A nonwoven fabric with a diameter of 170 mm and a thickness of
It was cut into a cylindrical shape of 0.20 mm and fixed in a column with an effective inner diameter of 160 mm and an internal space thickness of 5 mm. The total surface area on the blood inlet side of the resulting denatured blood component removal filter was 201 cm 2 /500 ml of stored blood.
Attach the above-mentioned denatured blood component removal filters at a height of 800 mm from the two 300 ml blood collection bags, and then attach one infusion bag 800 mm below to serve as a collection bag for storing the processed fluid. A processing device was created that was connected with tubes of 3 mm and outer diameter of 5 mm.

この処理装置の採血バツグ2個に、O型の健康
人のヘマトクリツト47%の21日間保存したCPD
液添加血液全血250mlずつを入れ、落差を利用し
た自然落下法により、4℃に保冷した上記保存血
をとり出し、ただちに室温10℃で1バツグずつ順
番に変性血液成分除去処理を行つた。
Two blood collection bags of this processing device contain CPD containing a hematocrit of 47% from a healthy type O person for 21 days.
Added whole blood (250 ml each) was added, and the stored blood kept cool at 4°C was taken out using a gravity drop method using a drop, and the denatured blood components were immediately removed one by one at a room temperature of 10°C.

つぎに、生理食塩水110mlを自然落下法により、
この変性血液成分除去フイルターに流し、フイル
ター内の血球を回収した。
Next, add 110ml of physiological saline using the gravity drop method.
The blood was passed through this denatured blood component removal filter, and the blood cells in the filter were collected.

その結果、この保存血液500mlの処理時間は6
分13秒であり、処理速度にして80ml/分という高
流速であつた。また、この21日間保存血の変性血
液成分の凝集物質が、処理前15μm以上で、2バ
ツグの平均が3.25×106個/ml存在したのが、処
理後は84500個/ml(凝集物質の除去率97.4%)
であつた。さらに、白血球の回収率は89.6%、赤
血球の回収率は89.7%であつた。
As a result, the processing time for 500ml of this stored blood was 6
The processing time was 80 ml/min, which was a high flow rate. In addition, the aggregated substances of denatured blood components in the blood stored for 21 days were 15 μm or more before treatment, and the average of 2 bags was 3.25 × 10 6 /ml, but after treatment, it was 84,500 aggregated substances / Removal rate 97.4%)
It was hot. Furthermore, the recovery rate of white blood cells was 89.6% and the recovery rate of red blood cells was 89.7%.

実施例 4 直径が7.8μmのポリエステル繊維を溶融ブロー
法で作成した嵩密度0.35g/cm2の繊維塊が繊維の
互いのもつれによつてその位置に固定されている
不織布を、直径210mm、厚さ0.30mmの円柱状に切
断し、有効内径200mm、内部空間部の厚さが5mm
のカラム中に固定した。得られた変性血液成分除
去フイルターの血液入口側の総表面積は449cm2
500ml−保存血であつた。200mlの採血バツグ2個
からそれぞれ落差800mmの位置に、上記に変性血
液成分除去フイルターをつけ、さらに800mm下方
に1の輸液バツグをつけて、処理した液を貯蔵
する回収バツグとし、その間をそれぞれ内径3
mm、外径5mmのチユーブで連結した処理装置を作
成した。
Example 4 A nonwoven fabric with a diameter of 210 mm and a thickness of Cut into a cylindrical shape with a diameter of 0.30 mm, an effective inner diameter of 200 mm, and an inner space thickness of 5 mm.
was fixed in a column. The total surface area of the obtained denatured blood component removal filter on the blood inlet side was 449 cm 2 /
500ml - stored blood. Attach a denatured blood component removal filter above two 200 ml blood collection bags at a height of 800 mm from each other, and attach one infusion bag 800 mm below to serve as a collection bag for storing the processed fluid. 3
A processing device was created that was connected with a tube with an outer diameter of 5 mm.

この処理装置の採血バツグ2個に、A型の健康
人のヘマトクリツト64%のCPD液添加血液濃厚
液(遠心分離法により1部血漿を除去したもの)
の10日間保存した血液175mlずつを入れ、落差を
利用した自然落下法により、室温25℃で1バツグ
ずつ順番に変性血液成分除去処理を行つた。
Two blood collection bags of this processing device are filled with a blood concentrate containing CPD solution (from which a portion of the plasma has been removed by centrifugation) of a healthy person with type A blood and a hematocrit of 64%.
175 ml of blood stored for 10 days was added to each bag, and denatured blood components were removed one by one at a room temperature of 25°C using a gravity drop method using a drop.

つぎに、生理食塩水160mlを自然落下法により、
この変性血液成分除去フイルターに流し、フイル
ター内の血球を回収した。
Next, add 160ml of physiological saline using the gravity drop method.
The blood was passed through this denatured blood component removal filter, and the blood cells in the filter were collected.

その結果、この保存血液350mlの処理時間は4
分7秒であり、処理速度にして85ml/分という高
流速であつた。また、この10日間保存濃厚血液の
変性血液成分の凝集物質が、処理前15μm以上で、
2バツグの平均が0.78×106個/ml存在したのが、
処理後は41300個/ml(凝集物質の除去率94.7%)
であつた。さらに、白血球回収率85.2%、赤血球
回収率87.8%であつた。
As a result, the processing time for 350ml of this stored blood was 4
The processing time was 85 ml/min, which was a high flow rate. In addition, if the agglutinated substances of denatured blood components in the concentrated blood stored for the past 10 days are 15 μm or more before processing,
The average of 2 batches was 0.78×10 6 pieces/ml,
After treatment: 41,300 pieces/ml (removal rate of aggregated substances: 94.7%)
It was hot. Furthermore, the leukocyte recovery rate was 85.2% and the red blood cell recovery rate was 87.8%.

実施例 5 直径が4.2μmのポリエステル繊維を溶融ブロー
法で作成した嵩密度0.28g/cm2の繊維塊が繊維の
互いのもつれによつてその位置に固定されている
不織布を、直径90mm、厚さ0.15mmの円柱状に切断
し、これを本フイルターとした。
Example 5 A nonwoven fabric with a diameter of 90 mm and a thickness of It was cut into a cylindrical shape with a diameter of 0.15 mm, and this was used as the present filter.

次いで、直径が14μmのポリエステル繊維の嵩
密度0.25g/cm2の熱固着した不織布を、直径90mm、
厚さ0.60mmの円柱状に切断し、これを大きな変性
血液成分を取る一層目のフイルターとした。この
一層目のフイルターを上記の本フイルターの上に
重ね、有効内径が80mm、内部空間部の厚さが6mm
のカラム中に固定した。得られた変性血液成分除
去フイルターの血液入口側の総表面積は63cm2
500ml−保存血であつた。200mlの採血バツグ2個
からそれぞれ落差が800mmの位置に、上記の変性
血液成分除去フイルター装置をつけ、さらに800
mm下方に1の輸液バツグをつけて、処理した液
を貯蔵する回収バツグとし、その間をそれぞれ内
径3mm、外径5mmのチユーブで連結した処理装置
を作成した。
Next, a heat-fixed nonwoven fabric made of polyester fibers with a diameter of 14 μm and a bulk density of 0.25 g/cm 2 was heated to a diameter of 90 mm.
It was cut into a cylindrical shape with a thickness of 0.60 mm, and this was used as the first layer filter to remove large denatured blood components. This first layer filter is stacked on top of the main filter above, and the effective inner diameter is 80 mm and the thickness of the internal space is 6 mm.
was fixed in a column. The total surface area on the blood inlet side of the obtained denatured blood component removal filter was 63 cm 2 /
500ml - stored blood. Attach the above-mentioned denatured blood component removal filter device at a height of 800 mm from two 200 ml blood collection bags, and then
A treatment device was constructed by attaching an infusion bag of 1 mm below the bag and using it as a collection bag to store the treated liquid, and connecting the bag with a tube having an inner diameter of 3 mm and an outer diameter of 5 mm.

この処理装置の採血バツグ2個に、いずれも
AB型の健康人のヘマトクリツト43%の21日間保
存したCPD液添加血液全血200mlずつを入れ、落
差を利用した自然落下法により、4℃に保冷した
上記保存血をとり出し、ただちに室温10℃で1バ
ツグずつ順番に変性血液成分除去処理を行つた。
In the two blood collection bags of this processing device, both
Add 200 ml of CPD solution-added whole blood stored for 21 days from a healthy person with blood type AB and a hematocrit of 43%, remove the stored blood kept cool at 4°C using the gravity drop method, and immediately transfer to room temperature of 10°C. The denatured blood components were removed one by one, one bag at a time.

つぎに、生理食塩水40mlを自然落下法により、
この変性血液成分除去フイルターに流し、フイル
ター内の血球を回収した。
Next, add 40ml of physiological saline using the gravity drop method.
The blood was passed through this denatured blood component removal filter, and the blood cells in the filter were collected.

その結果、この保存血液400mlの処理時間は5
分23秒であり、処理速度にして74ml/分という高
流速であつた。また、この21日間保存血の変性血
液成分の凝集物質が、処理前15μm以上で、2バ
ツグの平均が3.02×106個/ml存在したのが、処
理後は54400個/ml(凝集物質の除去率98.2%)
であつた。さらに、白血球の回収率90.8%、赤血
球の回収率91.5%であつた。
As a result, the processing time for 400ml of this stored blood was 5
The processing time was 74 ml/min, which was a high flow rate. In addition, the aggregated substances of denatured blood components in the blood stored for 21 days were 15 μm or more before treatment, and the average of 2 bags was 3.02 Removal rate 98.2%)
It was hot. Furthermore, the recovery rate for white blood cells was 90.8% and the recovery rate for red blood cells was 91.5%.

比較例 3 直径6.4μmのポリエステル繊維を溶融ブロー法
で作成した嵩密度0.35g/cm3の繊維塊が繊維の互
いのもつれによつてその位置に固定されている不
織布を、直径110mm、厚さ0.45mmの円柱状に切断
し、有効内径100mm、内部空間部の厚さが5mmの
カラム中に固定した。得られた変性血液成分除去
フイルターの血液入口側の総表面積は98cm2/500
ml−保存血であつた。300mlの採血バツク2個か
らそれぞれ落差800mmの位置に、上記の変性血液
成分除去フイルター装置をつけ、さらに800mm下
方に1の輸液バツグをつけて、処理した液を貯
蔵する回収バツグとし、その間をそれぞれ内径3
mm、外径5mmのチユーブで連結した処理装置を作
成した。
Comparative Example 3 A nonwoven fabric with a diameter of 110 mm and a thickness of polyester fibers of 6.4 μm in diameter and a bulk density of 0.35 g/cm 3 made by a melt-blowing method was fixed in place by the mutual entanglement of the fibers. It was cut into a cylindrical shape of 0.45 mm and fixed in a column with an effective inner diameter of 100 mm and an inner space thickness of 5 mm. The total surface area on the blood inlet side of the resulting denatured blood component removal filter was 98cm 2 /500
ml - stored blood. Attach the above-mentioned denatured blood component removal filter device at a height of 800 mm from the two 300 ml blood collection bags, and also attach one infusion bag 800 mm below, which serves as a collection bag to store the treated fluid, and between each Inner diameter 3
A processing device was created that was connected with a tube with an outer diameter of 5 mm.

この処理装置の採血バツグ2個に、B型の健康
人のヘマトクリツト38%の14日間保存したCPD
液添加血液全血200mlずつを入れ、落差を利用し
た自然落下法により、室温25℃で1バツグずつ順
番に変性血液成分除去処理を行なつた。
The CPD of a healthy person with type B blood, which had a hematocrit of 38%, was stored for 14 days in two blood collection bags of this processing device.
Added whole blood 200 ml of whole blood was added to each bag, and denatured blood components were removed one by one at room temperature of 25° C. using a gravity drop method using a drop.

つぎに、生理食塩水40mlを自然落下法により、
この変性血液成分除去フイルター装置に流し、フ
イルター装置内の血球を回収した。
Next, add 40ml of physiological saline using the gravity drop method.
The blood was passed through this filter device for removing denatured blood components, and the blood cells in the filter device were collected.

その結果、この保存血液400mlの処理時間は18
分11秒であり、処理速度にして22ml/分という低
速流であつた。また、この14日間保存血の変性血
液成分の凝集物質が、処理前15μm以上で、2バ
ツグの平均が1.84×106個/ml存在したのが、処
理後は0個/mlであつた。しかし、白血球回収率
は43.1%、赤血球回収率は90.7%であつた。
As a result, the processing time for 400ml of this stored blood is 18
The processing time was 11 minutes and 11 seconds, and the processing speed was 22 ml/min. In addition, the aggregated substances of denatured blood components in the blood stored for 14 days were 15 μm or larger before treatment, and the average of 2 bags was 1.84×10 6 particles/ml, but after treatment, it was 0 particles/ml. However, the leukocyte recovery rate was 43.1% and the red blood cell recovery rate was 90.7%.

比較例 4 直径14μmのポリエステル繊維を溶融ブロー法
で作成した嵩密度0.35g/cm3の繊維塊が繊維の互
いのもつれによつてその位置に固定されている不
織布を、直径78mm、厚さ0.30mmの円柱状に切断
し、有効内径100mm、内部空間部の厚さが5mmの
カラム中に固定した。得られた変性血液成分除去
フイルターの血液入口側の総表面積は45cm2/500
ml−保存血であつた。
Comparative Example 4 A nonwoven fabric with a bulk density of 0.35 g/cm 3 made of polyester fibers with a diameter of 14 μm by melt-blowing and fixed in position by the mutual entanglement of the fibers was fabricated with a diameter of 78 mm and a thickness of 0.30 μm. It was cut into a cylindrical shape of mm and fixed in a column with an effective inner diameter of 100 mm and an internal space thickness of 5 mm. The total surface area of the obtained denatured blood component removal filter on the blood inlet side is 45cm 2 /500
ml - stored blood.

300mlの採血バツグ2個からそれぞれ落差800mm
の位置に、上記の変性血液成分除去フイルター装
置をつけ、さらに800mm下方に1の輸液バツグ
をつけて、処理した液を貯蔵する回収バツグと
し、その間をそれぞれ内径3mm、外径5mmのチユ
ーブで連結した処理装置を作成した。
800mm head from two 300ml blood collection bags each
Attach the above-mentioned denatured blood component removal filter device at the position, and also attach an infusion bag 1 800 mm below to serve as a collection bag to store the treated fluid, and connect them with a tube with an inner diameter of 3 mm and an outer diameter of 5 mm. A processing device was created.

この処理装置の採血バツグ2個に、AB型の健
康人のヘマトクリツト42%の8日間保存した
CPD液添加血液全血200mlずつを入れ、落差を利
用した自然落下法により、室温25℃で1バツグず
つ順番に変性血液成分除去処理を行なつた。
A hematocrit of 42% from a healthy AB type patient was stored for 8 days in two blood collection bags of this processing device.
200 ml of CPD solution-added whole blood was added to each bag, and denatured blood components were removed one by one at a room temperature of 25° C. using a gravity drop method using a drop.

つぎに、生理食塩水40mlを自然落下法により、
この変性血液成分除去フイルター装置に流し、フ
イルター装置内の血球を回収した。
Next, add 40ml of physiological saline using the gravity drop method.
The blood was passed through this filter device for removing denatured blood components, and the blood cells in the filter device were collected.

その結果、この保存血液400mlの処理時間は3
分49秒であり、処理速度にして105ml/分という
高速流であつた。しかし、この8日間保存血の変
性血液成分の凝集物質が、処理前15μm以上で、
2バツグの平均が1.29×106個/ml存在していた
が、処理後も0.423×106個/ml残つていた。な
お、白血球回収率は88.2%、赤血球回収率は91.8
%であつた。
As a result, the processing time for 400ml of this stored blood was 3
The processing time was 105 ml/min, which was a high-speed flow. However, the agglutinants of denatured blood components in the blood stored for these 8 days were larger than 15 μm before treatment.
The average number of 2 bags was 1.29×10 6 cells/ml, but even after treatment, 0.423×10 6 cells/ml remained. The white blood cell recovery rate was 88.2% and the red blood cell recovery rate was 91.8.
It was %.

【図面の簡単な説明】[Brief explanation of the drawing]

第1図は本発明の変性血液成分除去フイルター
によるフイルター装置の一実施態様を示す正面
図、第2図は同縦断側面図、第3図は別の実施態
様を示す正面図、第4図は同縦断側面図、第5図
は本発明の変性血液成分除去フイルターによるフ
イルター装置の使用態様を示す説明図である。 1……フイルター装置本体、2,2′……丸盆
状枠体、3……リング部材、4,4′……突条、
5,5′……メツシユ状支持材、6……フイルタ
ー、7……血液流入管、8……血液流出管、9,
9′……パツキング、10,10′……丸盆状枠
体、11,11′……メツシユ状支持材、12…
…フイルター、13……血液流入管、14……血
液流出管、15,15′……パツキング、16…
…採血バツグ、17……回路、18……フイルタ
ー装置、19……回路、20……回収バツグ、2
1……生理食塩水バツグ、22……回路、23…
…回収バツグ、24……調整バルブ。
FIG. 1 is a front view showing one embodiment of a filter device using the denatured blood component removal filter of the present invention, FIG. 2 is a longitudinal sectional side view of the same, FIG. 3 is a front view showing another embodiment, and FIG. The longitudinal side view and FIG. 5 are explanatory diagrams showing how the filter device using the denatured blood component removal filter of the present invention is used. 1... Filter device main body, 2, 2'... Round tray-shaped frame body, 3... Ring member, 4, 4'... Projection,
5, 5'...Mesh-shaped support material, 6...Filter, 7...Blood inflow pipe, 8...Blood outflow pipe, 9,
9'... Packing, 10, 10'... Round tray-shaped frame, 11, 11'... Mesh-shaped support material, 12...
...Filter, 13...Blood inflow pipe, 14...Blood outflow pipe, 15, 15'...Packing, 16...
...Blood collection bag, 17...Circuit, 18...Filter device, 19...Circuit, 20...Collection bag, 2
1...Physiological saline bag, 22...Circuit, 23...
...Recovery bag, 24...Adjustment valve.

Claims (1)

【特許請求の範囲】[Claims] 1 繊維の直径が3〜10μm、嵩密度が0.05〜
0.45g/cm3で、繊維の互いにもつれにより固定さ
れた不織布からなり、その厚さが0.05〜0.35mmで
あり、かつ、その総表面積が15〜2000cm2/500ml
−保存血であることを特徴とする白血球を通過さ
せ変性血液成分のみを捕捉するための変性血液成
分除去フイルター。
1 Fiber diameter is 3 to 10 μm, bulk density is 0.05 to
0.45g/ cm3 , made of non-woven fabric fixed by intertwining of fibers, its thickness is 0.05~0.35mm, and its total surface area is 15~ 2000cm2 /500ml
- A denatured blood component removal filter for passing leukocytes and capturing only denatured blood components, which is characterized by being stored blood.
JP59050873A 1984-03-19 1984-03-19 Modified blood component removing filter Granted JPS60194959A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP59050873A JPS60194959A (en) 1984-03-19 1984-03-19 Modified blood component removing filter

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59050873A JPS60194959A (en) 1984-03-19 1984-03-19 Modified blood component removing filter

Publications (2)

Publication Number Publication Date
JPS60194959A JPS60194959A (en) 1985-10-03
JPH0566152B2 true JPH0566152B2 (en) 1993-09-21

Family

ID=12870837

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59050873A Granted JPS60194959A (en) 1984-03-19 1984-03-19 Modified blood component removing filter

Country Status (1)

Country Link
JP (1) JPS60194959A (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5316674A (en) * 1989-09-12 1994-05-31 Pall Corporation Device for processing blood for human transfusion
US5152905A (en) * 1989-09-12 1992-10-06 Pall Corporation Method for processing blood for human transfusion
JP6788370B2 (en) * 2015-04-03 2020-11-25 株式会社カネカ A connector for a cell separation device, a cell separation filter with the connector, and a method for producing a cell concentrate using the cell separation filter.
CN112969518A (en) * 2019-03-12 2021-06-15 泰尔茂株式会社 Filter device

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4972472A (en) * 1972-11-18 1974-07-12
JPS5558166A (en) * 1978-10-26 1980-04-30 Asahi Chemical Ind White corpuscle graduating filter and method of sampling white corpuscle
JPS6012578Y2 (en) * 1980-07-08 1985-04-23 三菱レイヨン株式会社 Fiber entanglement separation material

Also Published As

Publication number Publication date
JPS60194959A (en) 1985-10-03

Similar Documents

Publication Publication Date Title
JPH0213587B2 (en)
US4701267A (en) Method for removing leukocytes
CN102006876B (en) Aggregate-removing filter material and method for filtering blood preparations
KR950005186B1 (en) Apparatus and method for depleting leukocyte content in blood and blood components
CN100512891C (en) Method of removing leukocytes, leukocyte-removing filter and utilization thereof
JPS605309B2 (en) blood filtration media
US12370298B2 (en) Filtration unit for the leucocytapheresis of the blood, comprising a relief-perforated nonwoven
JPH0213588B2 (en)
US5540841A (en) Cardioplegia filter and method for processing cardioplegia fluid
US20010000204A1 (en) Method for removing tumor cells from tumor cell-contaminated stem cell products
JPH04240456A (en) Filter apparatus for removing leukocyte and method for using it
JPH0659304B2 (en) Blood component separation method
JPH0566152B2 (en)
JPH0534337A (en) Filter for separating leucocyte
JPH0817813B2 (en) Blood component separation equipment
JPH0545266B2 (en)
JP2918595B2 (en) White blood cell separator
JPS61128979A (en) Blood treatment apparatus
JP3088764B2 (en) Blood component separation method
JPS6223487Y2 (en)
JP4036304B2 (en) Cell capture / recovery method
JPH11290060A (en) Cell separation filter suitable for recovering cell, cell separation system and separation of cell
JP4384823B2 (en) Leukocyte removal filter device and leukocyte removal method
JP3635654B2 (en) Blood component collection device
JPH0528341U (en) Blood bag with air-bleeding bag and air-filled blood bag

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees